First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment - ...
With inflation remaining higher than normal, these practical strategies can help you save money, adjust your spending, and ...
Transparency remains central to public trust. Investigations need not be sensationalised to be credible. Excessive publicity can undermine due process and reinforce perceptions of media trials. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback